New Form 8-K - Qualigen Therapeutics, Inc. Filed: 2025-09-08 AccNo: 0001641172-25-026864 Size: 202 KB Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Director Khattar Jack A. 🟡 adjusted position in 55.6K shares (1 derivative) of SUPERNUS PHARMACEUTICALS, INC. (SUPN) at $46.01 ($6.3M) Transaction Date: Sep 05, 2025 | Filing ID: 000012